Mitochondrial structural alterations in ovarian cancer patient-derived xenografts resistant to cisplatin

Published May 15, 2021 | Version v1

Journal article Open

1. Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS Via Mario Negri 2, Milan 20156, Italy
2. Unit of Bio-Imaging, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS Via Mario Negri 2, Milan 20156, Italy
3. Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS Via Mario Negri 2, Milan 20156, Italy - Present address: Experimental Pharmacology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale"-IRCCS Via M.Semmola, Naples 80132, Italy
4. Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS Via Mario Negri 2, Milan 20156, Italy - Present address: Laboratory of Genomics of Cancer and Targeted Therapies, IFOM via Adamello 16, Milan 20156, Italy
5. Unit of Protein and Metabolite Biomarkers, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS Via Mario Negri 2, Milan 20156, Italy.
6. Clinic of Obstetrics and Gynecology, Department of Medicine and Surgery, University of Milan Bicocca, San Gerardo Hospital Monza 20900, Italy.
7. Unit of Bio-Imaging, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS Via Mario Negri 2, Milan 20156, Italy.

Immagini al microscopio elettronico dei campioni analizzati e dati relativi all'analisi

Files

Name	Size
raw data_IRCCS Ricci et al 2021.pdf md5:01f4ec0a477bebee2506015a0cb319dd	1.7 MB	Preview Download